SAIC Filings — Science Applications International Corporation - FilingSpy
SAIC
Science Applications International Corporation
A U.S. government technology and engineering contractor, SAIC (Science Applications International Corporation) provides IT modernization, artificial intelligence, digital engineering, and mission-systems support to the military, NASA, and intelligence agencies. Founded in 1969 in La Jolla, California, by physicist J. Robert Beyster, the company began with underwater-explosion studies for the Navy. In 2013 it split in two, with the larger piece renamed Leidos and this unit keeping the original name.
Q1 FY2027 operating income rose 48% to $179M on contract profitability and a $12M investment gain
rose 48% from a year ago. increased 1.5% to $1,906M and rose 83.8% to $2.61 as improved contract profitability and a $12M investment sale gain lifted to 9.4% from 6.4%. The company returned to earnings growth, but sits at $2,460M after a 31% annual increase.
Key takeaways
rose 47.9% to $179M and widened to 9.4% from 6.4% a year earlier, driven by improved contract portfolio profitability and a $12M gain from an investment sale.
rose 1.5% to $1,906M, with the SilverEdge acquisition contributing $19M and contract ramp-up offsetting completions; Defense and Intelligence revenue increased $33M to $1,466M while Civilian dipped $4M to $440M.
rose 83.8% to $2.61 and rose 69.1% to $115M .
Section summaries
Management's Discussion and Analysis
Q1 FY2027 revenue rose 2% to $1.9B; operating income jumped 48% on improved contract profitability and a $12M investment gain.
⌄
Consolidated grew $29M to $1,906M, driven by the SilverEdge acquisition ($19M) and ramp-up on existing and new contracts, partially offset by completions.
Defense and Intelligence increased $33M to $1,466M, while Civilian revenue dipped $4M to $440M due to contract completions.
rose to $221M (11.6% margin) from $158M (8.4% margin), with both segments improving.
rose 27.0% to $127M, aided by vendor payment timing and lower incentive compensation.
Total stood at $22.9B with $2.1B in ; was $2,460M, up 31.1% from a year earlier.
What changed
Q1 FY2027 rose 1.5% to $1,906M, answering the flagged watch for growth toward the prior ~7.4% adjusted pace — it remained in single digits for a fifth straight quarter.
was $2,460M, up 31.1% from $1,876M, continuing the increase flagged after the Q3 FY2026 draw to $2,475M; it eased 0.3% sequentially.
Civilian adjusted held its improved profitability after FY2026 rose to 13.6%, with Q1 FY2027 Civilian dipping $4M to $440M on completions.
Total was $22.9B versus $22.6B at FY2026 year-end, with $2.1B quarterly against the $7.8B FY2026 pace.
of $127M rose 27.0% , above the $100M Q1 FY2026 level and consistent with the FY2026 increase to $609M.
What to watch
Q2 FY2027 to see if underlying growth approaches the prior ~7.4% adjusted pace after five quarters of sub-6% movement.
movement from $2,460M as debt service and covenants apply after the 31.1% annual increase.
Civilian adjusted after the Q1 improvement alongside a $4M dip.
Total conversion from $22.9B as $2.1B quarterly ramp into .
margin expanded from 6.4% to 9.4%, reflecting improved contract portfolio profitability and a $12M gain from an investment sale.
rose to $221M (11.6% margin) from $158M (8.4% margin), with margins improving in both Defense and Civilian.
Net increased $27M to $127M, helped by vendor payment timing and lower incentive compensation, while financing outflows rose on higher share repurchases.
Total stood at $22.9B, with net of $2.1B for the quarter, and the company expects existing liquidity to meet near-term needs.
We have provided information about legal proceedings in which we are involved in our fiscal 2026 Annual Report on Form 10-K, and we have provided an update to this information in Note 11—Legal Proceedings and Other Commitments and Contingencies to the condensed consolidated fina…
⌄
We have provided information about legal proceedings in which we are involved in our fiscal 2026 Annual Report on Form 10-K, and we have provided an update to this information in Note 11—Legal Proceedings and Other Commitments and Contingencies to the condensed consolidated financial statements contained within this report, which is incorporated herein by reference.
In addition to the described legal proceedings, we are routinely subject to investigations and reviews relating to compliance with various laws and regulations. Additional information regarding such investigations and reviews is included in our fiscal 2026 Annual Report on Form 10-K, and we have also updated this information in Note 11—Legal Proceedings and Other Commitments and Contingencies to the condensed consolidated financial statements contained within this report, under the heading “Government Investigations, Audits and Reviews,” which is incorporated herein by reference.